Versatility, superior quality, and unparalleled partnership are the defining features of our industry-leading CGMP manufacturing services. The Gene Therapy team at Catalent combines leading expertise in recombinant AAV vector technology and scale-up with state-of-the-art CGMP facilities, including our EMA and FDA approved Harmans/BWI commercial facility. Our expert manufacturing teams are dedicated to optimal virus production and focused customization for your product. Each viral vector facility has multiple upstream and downstream manufacturing suites to accommodate parallel manufacturing campaigns.
At Catalent, we have produced a large number of clinical batches for trials and have a superior track record with both suspension and adherent transient transfections. Our robust supply chain management and integrated plasmid DNA services allow us to secure the critical manufacturing materials that will aid in de-risking your therapeutics.
Backed by years of success and an industry-leading team of scientists, Catalent Gene Therapy is your partner for advanced therapeutics manufacturing.